Positron Emission Tomography (PET) Predictors of Tumor Response to Peptide Receptor Radionuclide Therapy (PRRT) in Metastatic Neuroendocrine Tumors (NET)

被引：0
|
作者：
Ladwa, R. [1 ]
Pattison, D. [2 ]
Smith, J. [2 ]
Goodman, S. [2 ]
Burge, M. [3 ]
Rose, S. [4 ]
Dowson, N. [4 ]
Wyld, D. [3 ]
机构：
[1] Univ Queensland, Sch Med, Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
[2] Royal Brisbane & Womens Hosp, Nucl Med & Specialised PET Serv, Brisbane, Qld, Australia
[3] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Canc Care Serv, Brisbane, Qld, Australia
[4] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Brisbane, Qld, Australia
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
68ga-dotatate pet-ct; suv parameters; tumor response; somatostatin receptor tumor volume;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K11
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [21] Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
    Singh, Abhay
    Gravina, Matthew
    Tajammal, Rutaba
    Nowak, Annmarie
    Iyer, Renuka
    Faber, Mark G.
    Yan, LunBiao
    Hassane, Duane C.
    Guzman, Monica L.
    Mencia-Trinchant, Nuria
    Wang, Eunice S.
    Thota, Swapna
    BLOOD, 2020, 136
  • [22] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [23] Peptide receptor radionuclide therapy (PRRT) of midgut neuroendocrine tumors: assessment of quality of life
    Marinova, Milka
    Muecke, Martin
    Fischer, Felix
    Essler, Markus
    Cuhls, Henning
    Radbruch, Lukas
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [24] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
    Baum, Richard P.
    Puranik, Ameya D.
    Kulkarni, Harshad R.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 151 - 158
  • [25] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
    Duan, Heying
    Girod, Bradley
    Ninatti, Gaia
    Ferri, Valentina
    Kunz, Pamela
    Fisher, George
    Moradi, Farshad
    Davidzon, Guido
    Franc, Benjamin
    Iagaru, Andrei
    Aparici, Carina Mari
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [26] Efficacy of the Chronic Lanreotide Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP/NET) after Peptide Receptor Radionuclide Therapy (PRRT)
    Szalus, N.
    Kaminski, G.
    Podgajny, Z.
    Dziuk, E.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 137 - 137
  • [27] Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors
    Grey, Neil
    Silosky, Michael
    Lieu, Christopher H.
    Chin, Bennett B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (17) : 1768 - 1780
  • [28] Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors
    Neil Grey
    Michael Silosky
    Christopher H Lieu
    Bennett B Chin
    World Journal of Gastroenterology, 2022, (17) : 1768 - 1780
  • [29] Peptide Receptor Radionuclide Therapy (PRRT) in 35 Patients with Metastatic Neuroendocrine Neoplasms (NENs): Overall Response and Toxicity
    Liotsou, T.
    Stefanoyiannis, A.
    Alexandraki, K.
    Koumarianou, A.
    Angelousi, A.
    Kaltsas, G.
    Chatziioannou, S.
    NEUROENDOCRINOLOGY, 2018, 106 : 253 - 253
  • [30] Peptide Receptor Radionuclide Therapy (PRRT) of Neuroendocrine Tumor Patients with Carcinoid Heart Disease
    Prasad, V
    Secknus, M. A.
    Hoersch, D.
    Kuntze, T.
    Zachert, C.
    Baum, R. P.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 133 - 133
12345